Jospeh A Califano
University of California, San Diego
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jospeh A Califano as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:50 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05787639 · Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer)University of California, San Diego · active not recruiting · Oropharynx Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:50 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma.Clin Cancer Res · 2015163 citationsRCR 4.8
- 9 citationsRCR 0.3
- Evaluation of prophylaxis treatment of Candida in alaryngeal patients with tracheoesophageal voice prostheses.Laryngoscope · 20157 citationsRCR 0.4